Abstract
Joubert syndrome (JS) is a rare autosomal recessive syndrome characterised by agenesis or dysgenesis of the cerebellar vermis with accompanying brainstem malformations (OMIM: 213300). There is a distinctive (but not unique) MRI appearance in the posterior fossa of the brain termed the molar-tooth-sign, and the diagnosis of JS is usually made when this MRI finding is documented in an infant in combination with hypotonia, episodic hyperpnea or apnea, abnormal eye movements, with a variety of facial and other dysmorphisms. Later, developmental delay and cerebellar ataxia develop. In some JS patients a retinal dystrophy, coloboma and renal abnormalities manifest. It is apparent that JS is a clinically heterogeneous entity and that both intrafamilial and interfamilial variation exists. Overlap with other vermal hypoplasias and rare cerebellar-retinal-renal disorders exists, but whether such disorders are allelic to forms of JS awaits gene isolation and molecular clarification. Recently the first JS locus was found on chromosome 9q34 by homozygosity mapping in a consanguineous family of Omani origin. A second consanguineous family of similar ethnicity demonstrated haplotype segregation consistent with linkage to this 9q34 locus. Linkage to the 9q34 region was excluded in two additional consanguineous families, establishing genetic heterogeneity in the Joubert syndrome. Haplotype analyses in an additional 26 Joubert pedigrees including three with consanguinity, showed no evidence of homozygosity within this interval. These data suggest that the major JS genetic loci are yet to be discovered. Genes crucial to cerebellar and brainstem development are functional candidates, particularly homeotic genes specifying the vermal domain. We have excluded several strong functional candidate genes such as WNT1, EN1, EN2 and FGF8, by mutation analysis and direct DNA sequencing. To characterize the underlying molecular mechanism of the JS, it may be necessary to further define the syndrome. By careful examination, the JS can be distinguished from the related but genetically distinct syndromes, COACH, Senior-Loken and Arima.
Keywords: joubert syndrome, cerebellar vermian hypoplasia, brainstem malformation, js, cerebeller vermis
Current Genomics
Title: Clinical and Genetic Aspects of the Joubert Syndrome: a Disorder Characterised by Cerebellar Vermian Hypoplasia and Accompanying Brainstem Malformations
Volume: 4 Issue: 2
Author(s): C. L. Bennett, J. Meuleman, P. F. Chance and I. A. Glass
Affiliation:
Keywords: joubert syndrome, cerebellar vermian hypoplasia, brainstem malformation, js, cerebeller vermis
Abstract: Joubert syndrome (JS) is a rare autosomal recessive syndrome characterised by agenesis or dysgenesis of the cerebellar vermis with accompanying brainstem malformations (OMIM: 213300). There is a distinctive (but not unique) MRI appearance in the posterior fossa of the brain termed the molar-tooth-sign, and the diagnosis of JS is usually made when this MRI finding is documented in an infant in combination with hypotonia, episodic hyperpnea or apnea, abnormal eye movements, with a variety of facial and other dysmorphisms. Later, developmental delay and cerebellar ataxia develop. In some JS patients a retinal dystrophy, coloboma and renal abnormalities manifest. It is apparent that JS is a clinically heterogeneous entity and that both intrafamilial and interfamilial variation exists. Overlap with other vermal hypoplasias and rare cerebellar-retinal-renal disorders exists, but whether such disorders are allelic to forms of JS awaits gene isolation and molecular clarification. Recently the first JS locus was found on chromosome 9q34 by homozygosity mapping in a consanguineous family of Omani origin. A second consanguineous family of similar ethnicity demonstrated haplotype segregation consistent with linkage to this 9q34 locus. Linkage to the 9q34 region was excluded in two additional consanguineous families, establishing genetic heterogeneity in the Joubert syndrome. Haplotype analyses in an additional 26 Joubert pedigrees including three with consanguinity, showed no evidence of homozygosity within this interval. These data suggest that the major JS genetic loci are yet to be discovered. Genes crucial to cerebellar and brainstem development are functional candidates, particularly homeotic genes specifying the vermal domain. We have excluded several strong functional candidate genes such as WNT1, EN1, EN2 and FGF8, by mutation analysis and direct DNA sequencing. To characterize the underlying molecular mechanism of the JS, it may be necessary to further define the syndrome. By careful examination, the JS can be distinguished from the related but genetically distinct syndromes, COACH, Senior-Loken and Arima.
Export Options
About this article
Cite this article as:
Bennett L. C., Meuleman J., Chance F. P. and Glass A. I., Clinical and Genetic Aspects of the Joubert Syndrome: a Disorder Characterised by Cerebellar Vermian Hypoplasia and Accompanying Brainstem Malformations, Current Genomics 2003; 4 (2) . https://dx.doi.org/10.2174/1389202033350083
DOI https://dx.doi.org/10.2174/1389202033350083 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Current Pharmaceutical Design The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond
Current Pharmaceutical Design An Update in the Management of Obesity: The Weight of CNS Targets
Recent Patents on CNS Drug Discovery (Discontinued) Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
Current Medicinal Chemistry Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Effects of Natural Compounds on Xenopus Embryogenesis: A Potential Read Out for Functional Drug Discovery Targeting Wnt/β-catenin Signaling
Current Topics in Medicinal Chemistry Lipogenic Enzymes as Therapeutic Targets for Obesity and Diabetes
Current Pharmaceutical Design Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents PPARγ Pro12Ala Polymorphism in HIV-1-Infected Patients with HAARTRelated Lipodystrophy
Current HIV Research NPY and Cardiac Diseases
Current Topics in Medicinal Chemistry Interplay between Catalysts and Substrates for Activity of Class Ib Aminoacyl-tRNA Synthetases and Implications for Pharmacology
Current Topics in Medicinal Chemistry Basic Symptoms and the Prediction of First-Episode Psychosis
Current Pharmaceutical Design NPY Receptors as Drug Targets for the Central Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets Advances in Nanomaterials for Diagnosis and Therapy of Leukemia
Recent Patents on Nanomedicine Mitochondrial Membrane Lipids in Life and Death and their Molecular Modulation by Diet: Tuning the Furnace
Current Drug Targets Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Synthetic Cannabinoids as Drugs of Abuse
Current Drug Abuse Reviews Recombinant Hepatitis B Vaccination in Renal Failure Patients
Current Pharmaceutical Biotechnology